30th Mar 2007 17:10
Cyprotex PLC30 March 2007 Press Release 30 March 2007 Cyprotex PLC Director's Shareholding Name of Company CYPROTEX PLC Name of director ROBERT MORRISSON ATWATER 3. Please state whether notification indicates that it is in respect ofholding of the shareholder named in 2 above or in respect of a non-beneficialinterest or in the cast of an individual holder if it is a holding of thatperson's spouse or children under the age of 18 or in respect of anon-beneficial interest 2 ABOVE Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them (if notified) ROBERT MORRISSON ATWATER Please state whether notification relates to a person(s) connected with thedirector named in 2 above and identify the connected person(s) N/A Please sate the nature of the transaction. For PEP transactions please indicatewhether general/single co PEP and if discretionary / non discretionary MARKET PURCHASE Number of shares / amount of stock acquired 200,000 Percentage of issued class 0.14% Number of shares / amount of stock disposed N/A Percentage of issued class N/A Class of security ORDINARY SHARES OF 0.1 PENCE EACH Price per share 7.425 PENCE Date of transaction 30/3/2007 Date company informed 30/3/2007 Total holding following this notification 1,435,000 Total percentage holding of issued class following this notification 1.04% Any additional information N/A Name of contact and telephone number for queries MARK WARBURTON - 01625 505100 Name and signature of authorised company official responsible for making thisnotification MARK WARBURTON - COMPANY SECRETARY Date of Notification 30/3/2007 For further information: Cyprotex PLCRobert Morrison Atwater, CEOTel: +44 1625 505 [email protected] or Russell GibbsTel: +44 1625 505 [email protected] Media Enquires: WMC CommunicationsCharlie Geller/Alex GloverTel: +44 (0)20 7930 [email protected] This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CRX.L